Alzheimer’s Advocates Urge G7 to Accelerate Research and Healthcare Preparedness 09/10/2024 Maayan Hoffman Helen Rochford-Brennan, a 72-year-old Irish woman living with Alzheimer’s, was first diagnosed at 57, with a more complete diagnosis following five years later. At the time, there were no life-enhancing medications, leaving her to face the grim reality of her brain’s gradual decline, enduring what she described as “many dark days.” “Imagine having a new […] Continue reading -> Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
Three African Countries Have Eliminated Malaria. What’s Stopping The Others? 05/10/2024 Maayan Hoffman Three African countries—Algeria, Cabo Verde, and Mauritius—have successfully eliminated malaria, but dozens more still face this deadly disease. Globally, only 44 countries have eradicated malaria. The question of whether the rest of Africa catch up was explored in the latest Global Health Matters podcast, hosted by Dr. Garry Aslanyan. To delve into this issue, Aslanyan […] Continue reading -> WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
WHO Revises RSV Vaccine Guidance; Africa Chalks Up Gains in Campaigns on HPV, Measles and ‘Zero-Dose’ Children 02/10/2024 Elaine Ruth Fletcher For the first time ever, the World Health Organization (WHO) has recommended that pregnant women be vaccinated against respiratory syncytial virus (RSV), or that their newborns receive a dose of monoclonal antibodies to protect them against severe RSV disease, which has seen a global resurgence as the COVID-19 pandemic waned. In 2022-2023, RSV was the […] Continue reading -> Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
Investing in 24 Cents per Patient Annually in Digital Health Could Save 2 Million Lives 24/09/2024 Sophia Samantaroy Investing in as little as $0.24 per patient per year in digital health interventions – telemedicine, mobile messaging, and chatbots – could significantly lower the burden of non-communicable diseases (NCDs), says a new report from the World Health Organization (WHO) and the International Telecommunication Union (UTI). These interventions could avert 2 million deaths and 7 […] Continue reading -> More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
More Countries Are Addressing AMR, But Many Reluctant to Commit to Specific Cut to Animal Antibiotic Use 03/09/2024 Kerry Cullinan While more countries are concerned about antimicrobial resistance (AMR) than a decade ago, many are reluctant to commit to a specific target to reduce the overuse of animal antibiotics as they negotiate a political declaration ahead of the United Nations high-level meeting on AMR. The zero draft of the declaration issued on 20 May proposed […] Continue reading -> The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
The Global Response to Mpox: A Feeling of Déjà Vu? 23/08/2024 Janeen Madan Keller & Javier Guzman With the number of new mpox cases continuing to rise, and many more potentially undetected, African countries affected by the latest outbreak are racing to mobilize funds and urgently deploy medical countermeasures, including vaccines. But as the current epidemic unfolds, there is an undeniable feeling of déjà vu. Global efforts are falling short of what […] Continue reading -> Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
Caribbean Leaders Endorse New South-South Partnership – Next Stop Africa 13/08/2024 Elaine Ruth Fletcher The recent CARICOM summit of Caribbean leaders has endorsed a new Afro-Caribbean Health and Development (HeDPAC) initiative aimed at stimulating South-South collaboration on resilient health systems, health worker capacity building, and local medicines and vaccines manufacture. The formal CARICOM Communiqué at the close of the Summit in Grenada invited its 15 member states and five […] Continue reading -> WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
WHO Reaches Deal with Argentinian mRNA Vaccine Developer to Produce a Low-Cost Avian Flu Jab 29/07/2024 Elaine Ruth Fletcher The Argentina-based biotech firm, Sinergium Biotech, has agreed to share know-how on the production of an mRNA vaccine for Avian influenza (H5N1) with WHO’s Tecnology Transfer Hub so that an affordable vaccine could rapidly be produced for developing countries, WHO said Monday. The agreement marks the first time that a vaccine developer has actually volunteered […] Continue reading -> Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
Unlocking Innovation: Life Sciences Mentorship Session Offers New Insights 16/07/2024 Maayan Hoffman “Don’t be afraid to take risks. Think outside the box. Be agile. Adapt to change.” This was some of the advice young innovators in the life sciences field received last week during an interactive live mentorship session on the sidelines of the World Intellectual Property Organization (WIPO) General Assembly. Organized by WIPO and IFPMA (International […] Continue reading -> Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts
Unsettled by Spread of H5N1, US Invests in Moderna mRNA Vaccine for Flu 03/07/2024 Kerry Cullinan As H5N1 avian flu spreads in US dairy cows, the US Department of Health and Human Services (HHS) has granted approximately $176 million to Moderna to develop an mRNA-based vaccine for influenza with pandemic-potential. “We have successfully taken lessons learnt during the COVID-19 pandemic and used them to better prepare for future public health crises. […] Continue reading -> Posts navigation Older postsNewer posts